ARQT vs. SPY
Compare and contrast key facts about Arcutis Biotherapeutics, Inc. (ARQT) and SPDR S&P 500 ETF (SPY).
SPY is a passively managed fund by State Street that tracks the performance of the S&P 500 Index. It was launched on Jan 22, 1993.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ARQT or SPY.
Correlation
The correlation between ARQT and SPY is 0.28, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
ARQT vs. SPY - Performance Comparison
Key characteristics
ARQT:
4.99
SPY:
2.03
ARQT:
4.34
SPY:
2.71
ARQT:
1.51
SPY:
1.38
ARQT:
4.59
SPY:
3.02
ARQT:
19.96
SPY:
13.49
ARQT:
21.42%
SPY:
1.88%
ARQT:
85.62%
SPY:
12.48%
ARQT:
-95.02%
SPY:
-55.19%
ARQT:
-63.76%
SPY:
-3.54%
Returns By Period
In the year-to-date period, ARQT achieves a 314.86% return, which is significantly higher than SPY's 24.51% return.
ARQT
314.86%
42.10%
64.42%
423.44%
N/A
N/A
SPY
24.51%
-0.32%
7.56%
24.63%
14.51%
12.94%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ARQT vs. SPY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Arcutis Biotherapeutics, Inc. (ARQT) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ARQT vs. SPY - Dividend Comparison
ARQT has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 0.87%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ARQT Arcutis Biotherapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SPY SPDR S&P 500 ETF | 0.87% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% | 1.87% | 1.81% |
Drawdowns
ARQT vs. SPY - Drawdown Comparison
The maximum ARQT drawdown since its inception was -95.02%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for ARQT and SPY. For additional features, visit the drawdowns tool.
Volatility
ARQT vs. SPY - Volatility Comparison
Arcutis Biotherapeutics, Inc. (ARQT) has a higher volatility of 23.41% compared to SPDR S&P 500 ETF (SPY) at 3.64%. This indicates that ARQT's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.